Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Thermo Fisher Scientific
  6. News
  7. Summary
    TMO   US8835561023

THERMO FISHER SCIENTIFIC

(TMO)
  Report
Delayed Nyse  -  04:00 2022-06-24 pm EDT
544.81 USD   +0.78%
06/14S&P Upgrades Thermo Fisher Scientific One Notch To 'A-' On Expected Leverage Below 3x and Strong Demand; Outlook Stable
MT
06/14THERMO FISHER SCIENTIFIC : Ex-dividend day for
FA
06/10Illumina Shares Drop 10% After CFO Departure
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

IonPath, Inc. announced that it has received funding from Thermo Fisher Scientific Inc.

05/11/2022 EDT
share with twitter
share with LinkedIn
share with facebook

IonPath, Inc. announced that it has raised investment in a round of funding on May 11, 2022. The transaction included participation from new investor, Thermo Fisher Scientific Inc.


© S&P Capital IQ 2022
All news about THERMO FISHER SCIENTIFIC
06/14S&P Upgrades Thermo Fisher Scientific One Notch To 'A-' On Expected Leverage Below 3x a..
MT
06/14THERMO FISHER SCIENTIFIC : Ex-dividend day for
FA
06/10Illumina Shares Drop 10% After CFO Departure
DJ
06/09Illumina Says CFO Sam Samad to Depart July 8
DJ
06/09Thermo Fisher Scientific Inc Announces FDA Clears Thermo Scientific EliA RNA Pol III an..
CI
06/09Thermo Fisher Scientific Tests Get FDA Clearance
DJ
06/07Thermo Fisher Scientific Inc. Updates Applied Biosystems QuantStudio 5 Dx Real-Time PCR..
CI
06/06Thermo Fisher Scientific Inc. Showcases Solutions for Accelerating Next Generation Vacc..
CI
06/06Thermo Fisher Scientific Showcases Solutions for Accelerating Next Generation Vaccine a..
BU
06/06Thermo Fisher Scientific Collaborates with TransMIT GmbH on a High-Performance Orbitrap..
CI
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2022 42 489 M - -
Net income 2022 6 837 M - -
Net Debt 2022 25 165 M - -
P/E ratio 2022 31,6x
Yield 2022 0,22%
Capitalization 213 B 213 B -
EV / Sales 2022 5,61x
EV / Sales 2023 5,33x
Nbr of Employees 130 000
Free-Float 88,7%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 544,81 $
Average target price 661,95 $
Spread / Average Target 21,5%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
THERMO FISHER SCIENTIFIC-18.35%213 272
DANAHER CORPORATION-22.44%183 863
INTUITIVE SURGICAL, INC.-41.64%75 262
EDWARDS LIFESCIENCES CORPORATION-25.14%60 297
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-16.15%57 728
SIEMENS HEALTHINEERS AG-28.85%55 403